Skip to main content
Clinical Trials/NCT02953288
NCT02953288UnknownNot Applicable

Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules.

Shanghai 10th People's Hospital1 site in 1 country3,000 target enrollmentStarted: October 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
3,000
Locations
1
Primary Endpoint
Gene sequencing

Study Overview

Brief Summary

To investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.

Detailed Description

In previous studies, we have found highly prevalent TERT promoter mutations in aggressive thyroid cancers. So we plan to perform further research to investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.

Study Design

Study Type
Observational
Observational Model
Case Crossover
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient with thyroid nodule

Exclusion Criteria

  • Coagulant function abnormality

Outcomes

Primary Outcomes

Gene sequencing

Time Frame: 2 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Shanghai 10th People's Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Zhang Manna

Department of Endocrinology

Shanghai 10th People's Hospital

Study Sites (1)

Loading locations...

Similar Trials

Differential Diagnosis and Clinical... | Clinical Trial